BRPI1013079A2 - hidrofobinas para dispersao de agentes ativos - Google Patents

hidrofobinas para dispersao de agentes ativos

Info

Publication number
BRPI1013079A2
BRPI1013079A2 BRPI1013079A BRPI1013079A BRPI1013079A2 BR PI1013079 A2 BRPI1013079 A2 BR PI1013079A2 BR PI1013079 A BRPI1013079 A BR PI1013079A BR PI1013079 A BRPI1013079 A BR PI1013079A BR PI1013079 A2 BRPI1013079 A2 BR PI1013079A2
Authority
BR
Brazil
Prior art keywords
hydrophobins
active agents
dispersing active
dispersing
agents
Prior art date
Application number
BRPI1013079A
Other languages
English (en)
Inventor
Jouni Hirvonen
Palvi Laaksonen
Timo Laaksonen
Markus Linder
Hanna Valo
Original Assignee
Teknologian Tutkimuskeskus Vtt Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teknologian Tutkimuskeskus Vtt Oy filed Critical Teknologian Tutkimuskeskus Vtt Oy
Publication of BRPI1013079A2 publication Critical patent/BRPI1013079A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Ceramic Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1013079A 2009-06-09 2010-06-09 hidrofobinas para dispersao de agentes ativos BRPI1013079A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20095638A FI20095638A0 (fi) 2009-06-09 2009-06-09 Hydrofobiineja aktiivisten aineiden dispergointiin
PCT/FI2010/050475 WO2010142850A1 (en) 2009-06-09 2010-06-09 Hydrophobins for dispersing active agents

Publications (1)

Publication Number Publication Date
BRPI1013079A2 true BRPI1013079A2 (pt) 2017-06-06

Family

ID=40825343

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013079A BRPI1013079A2 (pt) 2009-06-09 2010-06-09 hidrofobinas para dispersao de agentes ativos

Country Status (10)

Country Link
US (1) US20120135081A1 (pt)
EP (1) EP2440248A4 (pt)
JP (1) JP2012529479A (pt)
CN (1) CN102802669A (pt)
AU (1) AU2010258531A1 (pt)
BR (1) BRPI1013079A2 (pt)
CA (1) CA2764828A1 (pt)
FI (1) FI20095638A0 (pt)
RU (1) RU2011152810A (pt)
WO (1) WO2010142850A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509921A (ja) * 2008-11-27 2012-04-26 ビーエーエスエフ ソシエタス・ヨーロピア 固形製薬学的処方物中への付形剤としての表面活性タンパク質
FI130619B (en) 2011-11-15 2023-12-15 Upm Kymmene Corp Matrix for sustained delivery of bioactive agents
US9556325B2 (en) 2012-07-10 2017-01-31 Cellutech Ab NFC stabilized foam
EP3335695B1 (en) * 2016-12-15 2020-02-05 UPM-Kymmene Corporation A method for freeze-drying hydrogel comprising nanofibrillar cellulose, a freeze-dried medical hydrogel comprising nanofibrillar cellulose, and a hydrogel comprising nanofibrillar cellulose
DK3335696T3 (da) * 2016-12-15 2020-03-16 Upm Kymmene Corp Fremgangsmåde til tørring af cellefrit vævsekstrakt i en hydrogel omfattende nanofibrillær cellulose og en tørret hydrogel omfattende nanofibrillær cellulose og cellefrit vævsekstrakt
JP7633678B2 (ja) 2018-10-26 2025-02-20 株式会社Reps Japan 液状溶液中に溶解する栄養素のコンパクトポッドおよびその製造方法
EP3791864A1 (en) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Method for preparing pharmaceutical composition and pharmaceutical composition
EP3791858A1 (en) * 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injectable pharmaceutical formulation
JP2022140110A (ja) * 2021-03-12 2022-09-26 日本製紙株式会社 食品用添加剤
WO2025196666A2 (en) * 2024-03-19 2025-09-25 Vexxel Biotech Corp. Hydrophobin-based capsules with target-sensitive release mechanism, compositions comprising thereof, and related methods
CN121800893B (zh) * 2026-03-11 2026-07-17 中国科学院生物物理研究所 用于冷冻电镜的电荷密度增强的疏水蛋白hfbi突变体载网膜及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092563A1 (en) * 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
GB0007770D0 (en) * 2000-03-30 2000-05-17 Biomade B V Protein capable of self-assembly at a hydrophobic hydrophillic interface, method of coating a surface, method of stabilizing a dispersion, method of stabilizi
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
WO2005068087A2 (en) * 2004-01-16 2005-07-28 Applied Nanosystems B.V. Method for coating an object with hydrophobin at low temperatures
CA2575325C (en) * 2004-07-27 2013-11-12 Unilever Plc Frozen food products containing hydrophobin
US7241734B2 (en) * 2004-08-18 2007-07-10 E. I. Du Pont De Nemours And Company Thermophilic hydrophobin proteins and applications for surface modification
DE102005027039A1 (de) * 2005-06-10 2006-12-21 Basf Ag Hydrophobin als Beschichtungsmittel für expandierbare oder expandierte, thermoplastische Polymerpartikel
DE102005029704A1 (de) * 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
EP2033619A1 (de) * 2007-08-24 2009-03-11 Basf Se Verfahren zum Dispergieren von ionischen Nanopartikeln
CA2698293A1 (en) * 2007-09-13 2009-03-26 Thomas Subkowski Use of hydrophobin polypeptides as penetration intensifiers
CN102089051A (zh) * 2008-07-11 2011-06-08 巴斯夫欧洲公司 作为形态学改变剂的两亲性蛋白质
JP2012509921A (ja) * 2008-11-27 2012-04-26 ビーエーエスエフ ソシエタス・ヨーロピア 固形製薬学的処方物中への付形剤としての表面活性タンパク質

Also Published As

Publication number Publication date
CN102802669A (zh) 2012-11-28
AU2010258531A1 (en) 2011-12-15
EP2440248A1 (en) 2012-04-18
US20120135081A1 (en) 2012-05-31
JP2012529479A (ja) 2012-11-22
CA2764828A1 (en) 2010-12-16
EP2440248A4 (en) 2013-02-13
WO2010142850A1 (en) 2010-12-16
RU2011152810A (ru) 2013-07-20
FI20095638A0 (fi) 2009-06-09

Similar Documents

Publication Publication Date Title
BR112012000687A2 (pt) tesoura para um endoscópio
EP2346734A4 (en) ACTIVE WINGLET
EP2564291A4 (en) ACTIVE VIBRATIONS
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BRPI1015203A2 (pt) agentes antimicrobianos
PT2556597T (pt) Estrutura de pré-codificador para pré-codificação mimo
BR112012014167A2 (pt) aparelho de barbear
FI20095638A0 (fi) Hydrofobiineja aktiivisten aineiden dispergointiin
EP2437351A4 (en) REFLECTION ARRAY
EP2478768A4 (en) AGGREGATE AGAINST PLANT VIRUSES
DK2640582T3 (da) Rulle
PT2598172T (pt) Catalisadores nucleofílicos para ligação oxima
BR112012006540A2 (pt) acessório para sutiã
BRPI1006968A2 (pt) microbiocidas
BRPI0913033A2 (pt) projeto de pad para mram-stt
ITPD20090053U1 (it) Paradordi per banchine
BRPI0924738A2 (pt) Herbicidas
BR112012010444A2 (pt) dispositivo para movimento lateral
BR112013011455A2 (pt) microbiocidas
FIU20090470U0 (fi) Aukirullain
DK2218841T3 (da) Brandmur
ES1072600Y (es) Consolador sexual
FR2947339B1 (fr) Granulometre perfectionne
ES1070148Y (es) Macolla para barrotes mejorada
ES1073433Y (es) Asiento para tareas pluriposturales

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07K 17/10 (2006.01), A23K 20/147 (2016.0